Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia

American Journal of Hematology

Volumn 63, Issue 4, 2000, Pages 170-175

  Liu, Ta Chih ^a   Lin, Pai Mei ^b   Chang, Jan Gowth ^c   Lee, Jing Ping ^a   Chen, Tyen Po ^a   Lin, Sheng Fung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Biological Science and Technology   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute myeloid leukemia; Loss of heterozygosity; PTEN MMAC1 gene; RT PCR

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; LEUKEMIA, MYELOID; LOSS OF HETEROZYGOSITY; PHOSPHORIC MONOESTER HYDROLASES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034101950     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200004)63:4<170::AID-AJH2>3.0.CO;2-0     Document Type: Article

References (35)

1. Bishop JM. The molecular genetics of cancer. Science 1987;235:305.
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319: 525.
3. Knudson AG. Genetics of human cancer. Annu Rev Genet 1989;20: 231.
4. Cline MJ. The molecular basis of leukemia. N Engl J Med 1994;330: 328.
5. th edition. New York: Wiley-Liss; 1994.
6. Rabbits TH. Chromosomal translocations in human cancer. Nature 1994;372:143.
7. Marshall CJ. Tumor suppressor genes. Cell 1991;64:313.
8. Yokota J, Sugimura T. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J 1993;7:920.
9. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943.
10. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford, LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. Identification of a candidate tumour suppressor gene. MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356.
11. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK. PTEN, the tumour suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 1997;94:9052.
12. Teng DH-F, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WKA, Fujii G, Berson A, Bookstein R, Bolen JB, Tavtigian SV, Steck PA. MMAC1/PTEN mutation in primary tumor specimens and tumor cell lines. Cancer Res 1997;57: 5221.
13. Liu TC, Lin SF, Chen TP, Liu HW, Chang JG. Mutation analysis of the ras gene in myelocytic leukemia by polymerase chain reaction and oligonucleotide probes. J Formos Med Assoc 1991;90:825.
14. Lin SF, Liu TC, Chen TP, Chiou SS, Liu HW, Chang JG. Diagnosis of thalassaemia by non-isotope detection of α/β and δ/β mRNA ratios. Br J Haematol 1994;87:133.
15. Lin PM, Liu TC, Chang JG, Chen TP, Lin SF. Aberrant TSG 101 transcripts in acute myeloid leukaemia. Br J Haematol 1998;102:753.
16. Furnari FB, Lin H, Huang HS, Cavence WK. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997;94:12479.
17. Ahmed Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. PTEN gene mutations in high-grade but not in low-grade gliomas. Cancer Res 1997;57:4187.
18. Cairns P, Okami K, Halachmi SH, Halachmi N, Esteller M, Herman JG, Jen J, Issacs WB, Bova GS, Sidransky D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 1997;57:4997.
19. Dahia PLM, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 1997;57:4710.
20. Gulderberg P, Straten PT, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 1997;57:3660.
21. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. PTEN/ MMAC1 mutations and EGFR amplification in glioblastoma. Cancer Res 1997;57:5254.
22. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/ MMAC1 in primary breast carcinoma. Cancer Res 1997;57:3657.
23. Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997;57:4736.
24. Tashiro H, Blazes MS, Wu R, Cho KR, Bose I, Wang SI, Li J, Parsons R, Ellenson LH. Mutation in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997;57:3935.
25. Wang SI, Pue J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Somatic mutations of PTEN in glioblasloma multiforme. Cancer Res 1997;57:4183.
26. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64.
27. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997;16:333.
28. Gayther SA, Barski P, Bailey SJ, Li L, de Foy KAF, Cohen SN, Ponder BAJ, Caldas C. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Oncogene 1997;15:2119.
29. Chang JG, Chen YJ, Perng LI, Wang NM, Kao MC, Yang TY, Chang CP, Tsai CH. Mutation analysis of the PTEN/MMAC1 gene in the cancer of digestive tract. Eur J Cancer 1999;35:647.
30. Wang NM, Chang JG. Are aberrant transcripts of FHIT, TSG101, and PTEN/MMAC1 oncogenesis related? Int J Mol Med 1999;3:491.
31. Haber D, Harlow E. Tumor-suppressor genes: Evolving definitions in the genomic age. Nat Genet 1997;16:320.
32. Lin PM, Liu TC, Chang JG, Chen TP, Lin SF. Aberrant FHIT transcripts in acute myeloid leukaemia. Br J Haematol 1997;99:612.
33. Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood 1998;92:3410.
34. McGlynn H, Kapelko K, Baker A, Burnette A, Padua RA. Allelic loss of the FMS gene in acute myeloid leukemia. Leuk Res 1997;21:919.
35. Padua RA, Guinn BA, Al-Sabah AI, Smith M, Taylor C, Pettersson T, Ridge S, Carter G, White D, Oscier D, Chevret S, West R. RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: A 10-year follow-up. Leukemia 1998;12:887.